StockCIK 1660334
Verrica Pharmaceuticals Inc. (VRCA): Insider Trades and Fund Holdings
In the past 12 months, Verrica Pharmaceuticals Inc. insiders reported 6 open-market purchases worth $211K and 0 sales worth $0.
6Insider buys, 12 months
$211KBought by insiders, 12 months
$0Sold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 18, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 18 | Jayson RiegerCEO | ▲ BUY | $101K |
| Aug 18 | David ZawitzCOO | ▲ BUY | $30K |
| Aug 18 | John J. KirbyCFO | ▲ BUY | $25K |
| Aug 18 | Jayson RiegerCEO | ▲ BUY | $25K |
| Aug 18 | Noah L. RosenbergCMO | ▲ BUY | $21K |
| Aug 18 | Noah L. RosenbergCMO | ▲ BUY | $10K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Jayson Rieger | CEO | 2 | $126K | 0 | $0 |
| David Zawitz | COO | 1 | $30K | 0 | $0 |
| John J. Kirby | CFO | 1 | $25K | 0 | $0 |
| Noah L. Rosenberg | CMO | 2 | $31K | 0 | $0 |
Tracked funds that report VRCA
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 21,769 | $133K | ▼ −32.7% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →